hs-10353
Showing 1 - 1 of 1
MDD Trial in Chengdu (HS-10353, Placebo)
Enrolling by invitation
- Major Depressive Disorder
- HS-10353
- Placebo
-
Chengdu, Sichuan, ChinaWest China Hospital
Jan 13, 2022